Webinar: Incorporation and Automation of RNAscope^™ Technology into your COVID-19 Viral Pathogenesis Research

Presented by:

Jyoti Phatak-Sheldon, M.S. 
Associate Scientist at Advanced Cell Diagnostics, a Bio-Techne brand

Andrea De Biase, M.S. 
Field Application Scientist at Advanced Cell Diagnostics, a Bio-Techne brand

Damian Cockfield 
Global Product Manager - BOND, Leica Biosystems
 

Outline:

Direct detection of viral RNA in human or other animal cells by RNA in situ hybridization (ISH) technology is a powerful tool to establish the etiology and pathogenesis of viral disease. Nucleic acid-based molecular detection methods have revolutionized viral detection, offering several essential advantages such as sensitivity, specificity, and speed.

Beyond this, RNAscope ISH technology uniquely offers a molecular detection at a single cell resolution coupled with morphological context to enable visualization of the virus in different infected tissues and cell types.

In this webinar, we will demonstrate how RNAscope technology can be used to detect viral infection and pathogenesis for research, and enhance our understanding of globally important viruses, such as SARS-CoV-2. For research labs that require high throughput and automated RNA (ISH) technology on BOND RX, Bio-Techne has partnered with Leica Biosystems to deliver RNAscope ISH automated assays. Here we present the Bio-Techne  products and technical suggestions to successfully execute RNAscope technology on BOND RX stainer from Leica Biosystems.
 

Learning Objectives:

• RNAscope Technology Overview - Learn how the RNAscope technology works and why it is great on the Leica BOND RX Research Platform
• See the proof - publications that show how COVID-19 Detection and Probes deliver the results researchers seek
• Learn about the COVID-19 Offerings (Bio-Techne) on the BOND RX stainer from Leica Biosystems